Advertisement
U.S. markets open in 31 minutes
  • S&P Futures

    5,306.00
    -2.25 (-0.04%)
     
  • Dow Futures

    40,169.00
    +25.00 (+0.06%)
     
  • Nasdaq Futures

    18,485.25
    -18.50 (-0.10%)
     
  • Russell 2000 Futures

    2,140.10
    +1.70 (+0.08%)
     
  • Crude Oil

    82.69
    +1.34 (+1.65%)
     
  • Gold

    2,229.10
    +16.40 (+0.74%)
     
  • Silver

    24.69
    -0.06 (-0.25%)
     
  • EUR/USD

    1.0808
    -0.0021 (-0.19%)
     
  • 10-Yr Bond

    4.2220
    +0.0260 (+0.62%)
     
  • Vix

    13.00
    +0.22 (+1.72%)
     
  • GBP/USD

    1.2641
    +0.0003 (+0.03%)
     
  • USD/JPY

    151.2090
    -0.0370 (-0.02%)
     
  • Bitcoin USD

    70,521.21
    +377.82 (+0.54%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,951.61
    +19.63 (+0.25%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Natco Pharma jumps on U.S. top court stance

Reuters Market Eye - Natco Pharma (NATP.NS) surges 6 percent after U.S. Supreme Court Chief Justice John Roberts denied a request by Teva Pharmaceutical Industries (TEVA.TA) to stay a lower-court ruling in a patent case that favoured the developers of generic versions of Teva's multiple sclerosis drug.

The decision could help pave the way for generic competitors of Teva's Copaxone drug, including Natco, to go on the market soon.

(Reporting by Abhishek Vishnoi)

Advertisement